drugset / Trial / NCT02633839
A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open label, parallel group study to evaluate the pharmacokinetics (PK) and safety of a single dose of CVT-301 in smoking and non-smoking adults.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-04
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levodopa | Small molecule | — | Inhaled |
| Background | Carbidopa | Unknown | — | Oral |
Indications
No indication recorded.